Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotine replacement therapy presented as an oral formulation for oral use. It helps adults who want to quit smoking by reducing nicotine withdrawal symptoms and cravings.

GNH USA supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability, regulatory compliance, and dedicated technical support throughout the supply chain.

Niquitin Mini, a nicotine replacement therapy, supports smoking cessation by alleviating nicotine withdrawal.

- Smoking cessation: helps reduce cravings and withdrawal symptoms, facilitating quitting. - Craving reduction: provides a controlled nicotine dose to lessen urge to smoke. - Relapse prevention: assists in maintaining abstinence after initial quitting.

Common and serious adverse reactions may occur with oral nicotine therapy.

Common Side Effects: - Nausea: mild stomach upset often reported. - Mouth irritation: soreness or tingling in the oral cavity. - Hiccups: transient episodes after dosing. - Dizziness: light‑headed sensation, usually brief. - Headache: mild to moderate intensity. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Arrhythmia: irregular heart rhythm requiring medical attention. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: possible indication of cardiovascular strain. - Hypertension: elevated blood pressure episodes. - Seizures: rare neurologic events. - Persistent vomiting: may lead to dehydration.

Before using Niquitin Mini, consider the following precautions to ensure safe and effective therapy.

- Assess cardiovascular status: patients with recent heart disease should use under medical supervision. - Evaluate psychiatric history: nicotine may exacerbate anxiety or mood disorders. - Review concomitant nicotine use: avoid combining with other nicotine products to prevent overdose. - Monitor blood pressure: nicotine can raise blood pressure in susceptible individuals. - Advise on proper dosing: follow prescriber instructions and do not exceed recommended amount. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Niquitin Mini can interact with other medicines; awareness of major and moderate interactions helps prevent adverse effects.

Major Interactions (Avoid): - Other nicotine products: concurrent use may cause nicotine toxicity. - CYP2A6 inhibitors (e.g., methoxsalen): can increase nicotine plasma levels. - Monoamine oxidase inhibitors: may enhance cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Antidepressants (SSRIs): increased risk of insomnia or agitation. - Antihypertensive agents: nicotine may reduce their efficacy. - Caffeine: combined stimulant effect may increase jitteriness. - Alcohol: may intensify nicotine’s cardiovascular effects.